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Objectives: Extended-spectrum β-lactamase (ESBL)-producing non-typhoidal Salmonella (NTS) isolates in
Korea were characterized.
Patients and methods: Five isolates of ESBL-producing NTS were isolated from stool specimens of three
infants and two adults with diarrhoea. Two infants acquired the infection in the community, and three other
infections were hospital acquired.
Results: The isolates were one each of serovars Saintpaul, Stanley and Agona, and two Enteritidis. Cell
sonicates of the isolates hydrolysed cefotaxime more efficiently than ceftazidime, and had β-lactamase
bands of approximate isoelectric points 6.0 and 7.4. Sequencing revealed that the β-lactamases were
TEM-52 and an OXA type. The blaOXA gene was located on a class 1 integron. Cefotaxime resistance, associ-
ated with TEM-52, was transferred by conjugation. Identical pulsed-field gel electrophoresis patterns of
XbaI-digested genomic DNA were observed in initially β-lactam-susceptible serovar Agona isolates and
subsequent ESBL-producing isolates from an infant, and in two isolates of serovar Enteritidis from two
different patients.
Conclusions: This study suggests that TEM-52-producing NTS is spreading both clonally and horizontally in
Korea.
Keywords: enteritis, class 1 integron, OXA-type β-lactamase
Introduction
Non-typhoidal Salmonella (NTS) is one of the most important enteric
pathogens worldwide. Antimicrobial treatment is required for NTS
gastroenteritis only when the patients are of extreme ages, or when
they have underlying diseases.1 Extended-spectrum β-lactamase
(ESBL) production is a particular concern, as expanded-spectrum
cephalosporins are the drugs of choice for children because they
cannot be treated with fluoroquinolones. Moreover, the ESBL genes
reside on conjugative plasmids and have the potential to spread to
other bacteria. TEM- and SHV-type ESBLs were first reported in
Korea in 1997,2 and the prevalent type was TEM-52.3 The aim of this
study was to determine the phenotypic and genetic characteristics of
ESBL-producing NTS strains isolated in Korea.
Materials and methods
Strains
NTS strains were isolated from stool specimens during 1995–1997 from
five in-patients with diarrhoea at a tertiary-care hospital. The species
were identified by conventional methods and the serovar was determined
by the National Institute of Health, Korea.
Antimicrobial susceptibility testing and β-lactamase 
investigation
The disc diffusion test4 was performed using commercial discs and
Mueller–Hinton agar (Becton Dickinson, Cockeysville, MD, USA).
ESBL production was determined by the double disc synergy test and
confirmed using the NCCLS broth dilution method.4
MICs of β-lactams were determined using an agar dilution test4 with
ampicillin and cefalothin (Sigma Chemical, St Louis, MO, USA), pipera-
cillin and tazobactam (Wyeth, Pearl River, NY, USA), cefotaxime
(Aventis, Frankfurt, Germany), ceftazidime and clavulanic acid (Glaxo-
SmithKline, Greenford, UK), aztreonam (Bristol-Myers Squibb, Princeton,
NJ, USA), and cefoxitin and imipenem (Merck, Sharp & Dohme, Rahway,
NJ, USA).
Isoelectric points (pI) of β-lactamases were determined by loading
cell sonicates on pre-cast gels and separating them by use of a Thermo-
Flow Electrophoresis Temperature Control System (Novel Experimental
Technology, San Diego, CA, USA). The bands were visualized using
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nitrocefin solution. β-Lactamase activities of the cell sonicates were
determined using a model UV-2401 spectrophotometer (Shimadzu,
Tokyo, Japan) with 100 µM solutions of β-lactams in 50 mM phosphate
buffer (pH 7.0) at 30°C. Results were expressed as relative activity versus
that observed with penicillin G.5
PCR amplification and sequencing
Alleles of blaTEM and blaSHV were detected using previously reported
primers and reaction conditions.2 For blaTEM sequencing, a PCR product
of 1080 bp was amplified using primers: TEM-SF, 5′-ATAAAAT-
TCTTGAAGACGAAA-3′ and TEM-SR, 5′-GACAGTTACCAAT-
GCTTAATC-3′. A PCR product from the class 1 integron was obtained
using previously reported primers and reaction conditions.6 The nucle-
otide sequence was determined by direct sequencing on an ABI 3700
Automatic sequencer (Perkin-Elmer, Foster City, CA, USA). Both
strands were sequenced twice with independent amplicons.
Plasmid study and pulsed-field gel electrophoresis (PFGE)
Plasmids were isolated by the alkaline lysis method, and after electro-
phoresis their sizes were estimated by comparison with those of
Escherichia coli strain V517. Conjugation was performed by the broth
mating method using rifampicin-resistant E. coli strain RG 488 and
nalidixic acid-resistant E. coli strain RG 176 as recipients.
Genomic DNA of the NTS isolates was digested using XbaI, and the
bands were separated using a CHEF-DRII system according to the manu-
facturer’s instruction (Bio-Rad, Hercules, CA, USA). The band patterns
were compared visually.
Results and discussion
Clinical findings
Two infants with no underlying diseases were admitted because of
diarrhoea, but one infant and two adults developed diarrhoea during
hospitalization to treat underlying diseases. One strain each of
Salmonella serovars Saintpaul, Stanley and Agona were isolated
from three patients, and two strains of serovar Enteritidis were iso-
lated from two different patients (Table 1). Sporadic or nosocomial
outbreaks of ESBL-producing NTS infections have been reported in
many countries. It was reported that four of 26 consecutive isolates of
community-acquired serovar Typhimurium in Turkey produced
ESBLs.7
Except for the initial isolates of serovar Agona, all other isolates
produced ESBLs. Strains of serovar Agona, which were susceptible
to β-lactams, aminoglycosides, co-trimoxazole and ofloxacin, were
isolated initially from one infant, and persisted until the eighteenth
hospital day culture. The patient was treated with cefaclor and ESBL-
producing strains of the same serovar were isolated from a specimen
taken 41 days after the initial isolation of the susceptible strains.
Follow-up stool culture from three infants showed persistence of
the same serovar for 1–7 weeks. The carriage was probably pro-
longed because all of the patients were treated with antimicrobial
agents for other diseases, none of which was recommended for the
treatment of NTS enteritis.
Antimicrobial resistance and β-lactamase investigation
In our study, all ESBL-producing isolates and the transconjugants
were resistant to multiple β-lactams, but susceptible to cefoxitin, imi-
penem and ofloxacin. Susceptibility to aminoglycosides and co-
trimoxazole was variable: isolates and the transconjugants of serovars
Saintpaul and Enteritidis were resistant to amikacin, netilmicin and
tobramycin, but susceptible to gentamicin; serovars Stanley and
Agona were resistant to gentamicin and tobramycin, but susceptible
to amikacin and netilmicin. All isolates and the transconjugants
except serovar Stanley were resistant to co-trimoxazole.
The MICs of cefotaxime were equal to or lower than those of
ceftazidime for all the ESBL-producing isolates tested, but cefotaxime
was hydrolysed more efficiently than ceftazidime, as reported in
other TEM-52-producing isolates.8 The MICs of all β-lactams were
decreased by the addition of clavulanic acid, but those of piperacillin
did not decrease significantly after addition of tazobactam in  three
isolates.
Isoelectric focusing showed β-lactamase bands of pI ∼5.4 and
∼6.0 in two isolates, suggesting TEM-type enzymes, but in three iso-
lates with high MICs of piperacillin-tazobactam, bands of pI ∼6.0 and
∼7.4 were observed indicating the presence of other β-lactamases
(Table 2).
Table 1. Clinical features of the patients with ESBL-producing NTS isolation from stool
M, male; F, female; ND, not determined; S, β-lactam susceptible; R, β-lactam resistant.
Case no.
Sex/age 
(years)
Underlying 
diseases Present illness
Salmonella 
serovar
Persistent 
isolation Treatment
1 M/0.4 none diarrhoea Saintpaul 7 weeks cefaclor, 
co-trimoxazole
2 F/1 agenesis of 
corpus callosum
diarrhoea, pneumonic 
consolidation
Stanley 1 week cefoperazone, 
amikacin 
3 M/1 none diarrhoea Agona (S), 
Agona (R)
18 days, 
13 days
cefaclor, 
co-trimoxazole
4 F/25 osteosarcoma diarrhoea 1 month 
after admission
Enteritidis ND cefotaxime
5 F/51 mitral valve 
replacement
diarrhoea 1 month 
after admission
Enteritidis ND cefoperazone, 
tobramycin
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Table 2. Characteristics of ESBL-producing NTS isolates and their transconjugants
CTX, cefotaxime; CAZ, ceftazidime; ATM, aztreonam; PIP, piperacillin; CLV, clavulanic acid; TAZ, tazobactam; CI, clinical isolate; TC, transconjugants; S, susceptible isolate; R, resistant isolate;
NT, not tested.
aMICs (mg/L) of ampicillin, cefalothin, cefoxitin and imipenem were >256, >256, ≤4 and ≤0.25, respectively, against all ESBL-producing isolates and their transconjugants. All ESBL-producing iso-
lates and the transconjugants were susceptible to ofloxacin.
bRelative hydrolysis compared with that of penicillin G.
MIC (mg/L)a Relative hydrolysis (%)b PCR
Case no., strain no. CTX
CTX + 
CLV CAZ
CAZ + 
CLV ATM
ATM + 
CLV PIP
PIP + 
CLV
PIP + 
TAZ CTX CAZ ATM pI blaTEM blaOXA
(1) Salmonella Saintpaul, 
95/4/4199
CI 128 1 128 2 16 0.5 >256 16 >128 66 2 2 6.0, 7.4 + +
TC 32 0.25 32 0.5 8 0.25 >256 8 128 97 6 6 6.0, 7.4 + +
(2) Salmonella Stanley, 
96/7/4034
CI 256 0.5 256 2 32 0.5 >256 8 4 56 2 4 5.4, 6.0 + –
TC 16 0.12 32 0.5 8 0.12 >256 2 2 76 4 <1 5.4, 6.0 + –
(3) Salmonella Agona, 
96/9/4280 (S) 
CI 0.12 0.12 0.5 0.5 0.12 0.12 2 2 4 NT NT NT NT NT NT
Salmonella Agona, 
96/10/4368 (R)
CI 128 0.5 >256 2 16 0.25 >256 4 4 61 4 <1 5.4, 6.0 + –
TC 32 0.12 32 0.5 4 0.12 >256 4 1 54 4 2 5.4, 6.0 + –
(4) Salmonella Enteritidis, 
97/4/4434
CI 128 1 128 2 16 0.5 >256 16 >128 33 5 3 6.0, 7.4 + +
TC 32 0.25 32 0.5 4 0.12 >256 8 16 90 8 3 6.0, 7.4 + +
(5) Salmonella Enteritidis, 
97/8/4419
CI 32 1 128 1 8 0.12 >256 4 >128 85 6 9 6.0, 7.4 + +
TC 32 0.25 16 0.5 4 0.12 >256 4 16 123 15 10 6.0, 7.4 + +
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Genetic characteristics
By PCR analysis, alleles of blaTEM were detected in all of the strains,
and those of blaOXA in three strains with a β-lactamase band of pI ∼7.4
(Table 2). Sequencing of the blaTEM amplicon showed deduced
amino acid changes of Glu-104→Lys, Met-182→Thr and Gly-
238→Ser from TEM-1, which correspond to TEM-52 β-lactamase
(GenBank accession no. AF126444).
Presence of a class 1 integron was detected by PCR in strains with
β-lactamase band of pI∼7.4. Sequencing showed that the integron
carried aacA4, an unknown orf, and blaOXA1 (GenBank accession no.
AY220520). blaOXA1 (not blaOXA-1) was identical to that reported
from a sludge sample (GenBank accession no. AY139600). Class 1
integrons, carrying various resistance gene cassettes, were reported
in 76% of serovar Typhimurium DT104 and 48% of the non-phage-
typeable strains in Spain.9
Our isolates had plasmids of >120 MDa (data not shown). The
plasmids carrying ESBL genes are usually large in size, i.e. ≥80 kb,
although one study showed that blaTEM-52 gene was carried on a mobil-
izable plasmid of 13.5 kb in a Klebsiella pneumoniae isolate.8 The
resistance to expanded-spectrum cephalosporins was co-transferred
to recipients together with resistance to aminoglycosides and co-
trimoxazole, if present. These results indicate that blaTEM-52-carrying
plasmids with diverse genetic characteristics had been spreading
among the NTS.
Epidemiological features
ESBL-producing salmonellae are extremely rare, but recently their
prevalence was reported to be 3.4% in western Pacific countries.10
TEM-52 ESBL in NTS was first found in a Yugoslavian patient.
Detection of TEM-52-producing salmonellae is not unusual in
Korea, as TEM-52-producing E. coli and K. pneumoniae are pre-
valent.3 However, it is interesting that the five isolates belonged to
four different serovars, although the most frequently isolated serovars
were Typhimurium and Enteritidis (data not shown).
Two serovar Enteritidis strains isolated from two different
patients 4 months apart had an identical antimicrobial resistance
pattern and an identical PFGE pattern, suggesting that they belonged
to an identical clone. The ESBL-producing and -non-producing
strains of serovar Agona from a patient had an identical PFGE
pattern, suggesting acquisition of resistance.
In conclusion, isolation of five strains of TEM-52 ESBL-producing
NTS with four different serovars, three different resistance patterns
and different genetic characteristics suggests that resistance is
spreading both clonally and horizontally to NTS in Korea, not only in
hospital, but also in the community.
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